The field of Hepatitis C Virus (HCV) treatment is changing at a rapid pace with the advent of highly effective directly acting agents (DAAs); the challenges of treating co-infected patients are significant.
Our understanding of hepatitis B (HBV) and the increasing cases of reactivation of hepatitis B with immunosuppression and treatment of hepatitis C has re-emphasized the importance of understanding about the diagnosis, prevention, and management of this infection.
Although the primary mission of the AETCs is focused on HIV, viral hepatitis is increasingly important both independent of and related to HIV. Risk factors for acquisition of these viral infection is similar to HIV and management recommendation guidelines are frequently updated. In the U S, approximately 730,000 people are chronically infected with hepatitis B virus (HBV), while over 2.7 million people are chronically infected with hepatitis C virus (HCV).
The SCAETC offers a wide array of training programs including didactic presentations, interactive workshops, case discussions, preceptorships, consultations, technical advisement with continuing education credits at no cost to participants.
Trainings are offered in-person or virtually – both live and self-paced trainings. Trainings are customized to those with varied levels of expertise and can be specifically targeted to the individual or clinical site. Please browse our Training calendar to find events happening in your area.
Browse our Training Calendar to see events happening this month in your area!
Simply click on the event that interests you and you will be taken to a page to learn more about it and to self-register.
This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS). Under grant number U1OHA33225 (South Central AIDS Education and Training Center). It was awarded to the University of New Mexico. No percentage of this project was financed with non-governmental sources. This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.
